Philip John Brooks | Health Scientist Administrator
NIH

Philip John Brooks, Health Scientist Administrator, NIH

Philip John (P.J.) Brooks, Ph.D.
Program Director, Director of Clinical Innovation
National Center for Advancing Translational Sciences (NIH)
Philip John (P.J.) Brooks joined the NCATS Division of Clinical Innovation (DCI) as a program director in January 2015. He is the lead program director for the Clinical and Translational Science Awards (CTSA) Program Collaborative Innovation Awards, designed to fund projects that will result in novel and creative approaches to overcoming roadblocks in translational science (PAR-15-173 (link is external)). He also represents NCATS on the Trans-NIH Microbiome Working Group and Gene Therapy Working Group, and participates in the NIH Common Fund programs on Extracellular RNA Communication. He also works with the Office of Rare Diseases Research as a liason to several consortia within the Rare Disease Clinical Research Network (RDCRN).
 
Brooks earned bachelor’s and master’s degrees in psychology and received his Ph.D. in neurobiology from the University of North Carolina at Chapel Hill. After completing a postdoctoral fellowship at the Rockefeller University, Brooks became an investigator in the intramural program of the National Institute on Alcohol Abuse and Alcoholism (NIAAA). He developed an internationally recognized research program focused on two distinct areas: the molecular basis of alcohol-related cancer, and rare neurologic diseases resulting from defective DNA repair. In addition to his position with DCI, Brooks is a guest researcher in the NIAAA Laboratory of Neurogenetics.

Appearances:



Microbiome World Congress USA Day 1 2017 @ 11:40

Presentation: Clinical innovations in Microbiome: From wellness to treatment

Commercial
  • The proper regulation of Microbiome is essential if the field is to be taken seriously as a viable treatment for diseases.
  • How do we move away from the wild west like scene of dietary supplements?
  • What can we learn from recent partnerships and breakthroughs?

back to speakers